journal article·2023-07-11

Mineralized Porphyrin Metal–Organic Framework for Improved Tumor Elimination and Combined Immunotherapy

Yun Yu, Bo-Ru Xie, Xin-Hua Liu, Jing-Jie Ye, Zhenlin Zhong, Xian-Zheng Zhang

ACS Nano· Volume 17· Issue 13
Publisher page

Abstract

Calcium ion therapy is a potential anticancer treatment. However, the cellular calcium-buffering mechanism limited the effectiveness of calcium ion therapy. Here, we constructed a mineralized porphyrin metal–organic framework (PCa) to produce calcium ions and reactive oxygen species (ROS), which destroyed cell calcium buffering capacity and amplified the cell damage caused by calcium overload. In addition, PCa could induce cell immunogenic death to release tumor-associated antigen (TAA) and be used as an adjuvant. Thus, PCa could increase DC maturation and promote the antitumor activity of CD8 + T cells. For mice experiment, PCa not only showed excellent tumor elimination on the subcutaneous breast tumor but also achieved obvious antimetastasis effect in the metastatic tumor model. This nanosystem could eliminate the primary tumor and boost effective antitumor immunotherapy for comprehensive anticancer treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery · Adenosine and Purinergic Signaling

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, P. R. China

Funding

National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.3322/caac.2170810.3322/caac.21708 ↗
2. 10.1038/3503603510.1038/35036035 ↗
3. 10.1038/nrm115010.1038/nrm1150 ↗
4. 10.1016/j.chempr.2019.06.00310.1016/j.chempr.2019.06.003 ↗
5. 10.1016/j.apsb.2016.11.00110.1016/j.apsb.2016.11.001 ↗
6. 10.1021/acsnano.8b0203410.1021/acsnano.8b02034 ↗
7. 10.1016/j.it.2020.06.01210.1016/j.it.2020.06.012 ↗
8. 10.1038/nature1169910.1038/nature11699 ↗
9. 10.1016/j.celrep.2019.03.01110.1016/j.celrep.2019.03.011 ↗
10. 10.1002/biof.14210.1002/biof.142 ↗
11. 10.1016/j.tibs.2016.09.00110.1016/j.tibs.2016.09.001 ↗
12. 10.1038/emboj.2011.33710.1038/emboj.2011.337 ↗
13. 10.1021/acs.chemrev.1c0038110.1021/acs.chemrev.1c00381 ↗
14. 10.1021/jacs.7b0789510.1021/jacs.7b07895 ↗
15. 10.1021/jacs.6b0000710.1021/jacs.6b00007 ↗
16. 10.1021/acscentsci.8b0082210.1021/acscentsci.8b00822 ↗
17. 10.1002/adma.20190049910.1002/adma.201900499 ↗
18. 10.1021/acsnano.9b0030010.1021/acsnano.9b00300 ↗
19. 10.1016/j.biomaterials.2019.11950010.1016/j.biomaterials.2019.119500 ↗
20. 10.1002/admi.20210109710.1002/admi.202101097 ↗
21. 10.1039/C6CS00746E10.1039/C6CS00746E ↗
22. 10.1021/nn507485j10.1021/nn507485j ↗
23. 10.1002/adhm.20120014910.1002/adhm.201200149 ↗
24. 10.1002/adma.20200208510.1002/adma.202002085 ↗
25. 10.1016/j.vaccine.2004.06.02910.1016/j.vaccine.2004.06.029 ↗
26. 10.1016/j.biomaterials.2010.03.06710.1016/j.biomaterials.2010.03.067 ↗
27. 10.1016/j.biomaterials.2018.02.03310.1016/j.biomaterials.2018.02.033 ↗
28. 10.1126/sciadv.aax503210.1126/sciadv.aax5032 ↗
29. 10.1016/j.biomaterials.2022.12162810.1016/j.biomaterials.2022.121628 ↗
30. 10.1016/j.biomaterials.2021.12135810.1016/j.biomaterials.2021.121358 ↗
31. 10.1016/j.celrep.2020.10832710.1016/j.celrep.2020.108327 ↗
32. 10.1039/C8CS00489G10.1039/C8CS00489G ↗
33. 10.1002/adma.20210227110.1002/adma.202102271 ↗
34. 10.1021/acsnano.5b0107710.1021/acsnano.5b01077 ↗
35. 10.1021/acs.nanolett.1c0081810.1021/acs.nanolett.1c00818 ↗
36. 10.1002/adma.20190092710.1002/adma.201900927 ↗
37. 10.1002/anie.20191142910.1002/anie.201911429 ↗
38. 10.1002/anie.20180488210.1002/anie.201804882 ↗
39. 10.1038/s41467-018-04425-z10.1038/s41467-018-04425-z ↗
40. 10.1039/D0NR04213G10.1039/D0NR04213G ↗
41. 10.1126/sciadv.aay778510.1126/sciadv.aay7785 ↗
42. 10.1016/j.jconrel.2019.01.02710.1016/j.jconrel.2019.01.027 ↗
43. 10.1126/scitranslmed.aal360410.1126/scitranslmed.aal3604 ↗
44. 10.31635/ccschem.020.20200014010.31635/ccschem.020.202000140 ↗
45. 10.1002/cptc.20200014210.1002/cptc.202000142 ↗
46. 10.1016/j.biomaterials.2021.12101310.1016/j.biomaterials.2021.121013 ↗
47. 10.1002/adma.20210397810.1002/adma.202103978 ↗
48. 10.1002/adfm.20160067610.1002/adfm.201600676 ↗
49. 10.31635/ccschem.020.20200020110.31635/ccschem.020.202000201 ↗
50. 10.1002/adma.20210079510.1002/adma.202100795 ↗